New Delhi, April 1 (IANS) The Drug Controller General of India has stepped up regulatory surveillance against unauthorised sale and promotion of type 2 diabetes drugs also known as GLP-1 drugs, the government said on Wednesday.In recent weeks, 49 businesses were audited and inspected across the country, including online pharmacy warehouses, drug wholesalers, retailers, and weight loss clinics, an official statement said.These inspections spanned multiple regions across India and focused on ident…
Latest Type 2 Diabetes News & Updates
New Delhi, March 29 (IANS) Abdominal or central obesity poses a greater health risk than overall obesity, especially in the Indian context, where even lean-looking individuals may carry harmful visceral fat, Union Minister Dr Jitendra Singh said on Sunday.Speaking at the release of a cardiology textbook titled “Advances in Obesity and Lipid Management in CVD”, the minister highlighted that fat accumulation around the abdomen can significantly increase the risk of serious health conditions, even …
New Delhi, March 27 (IANS) Major drug maker Dr. Reddy’s Laboratories on Friday told the Delhi High Court that it will change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’, a report said on Friday.The company informed the court that it would propose a new brand name following the judge’s observation that the existing name could lead to confusion in a pharmaceutical setting.The dispute comes as India opens up to generic versions of semaglutide following patent expiry, trigg…
Chennai, March 25 (IANS) The Madras High Court has granted liberty to the Greater Chennai City Police (GCCP) to arrest YouTuber ‘Savukku’ Shankar alias A. Shankar, if his custody is required in connection with an extortion case, while refusing to extend the interim bail earlier granted to him on medical grounds. A Division Bench comprising Justices P. Velmurugan and M. Jothiraman declined to prolong the three-month interim bail that had been granted on December 27, 2025, by a vacation Ben…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…
New Delhi, Jan 9 (IANS) Daylight can help improve metabolic health, enabling people with type 2 diabetes to achieve better glycaemic control, according to a study.Researchers from the University of Geneva (UNIGE) in Switzerland and Maastricht University in the Netherlands found that people exposed to natural light had blood glucose levels in the normal range for more hours per day, with less variability.In addition, their melatonin level — the sleep hormone — was a little higher in the evening…
New Delhi, Jan 5 (IANS) Type 2 diabetes quietly changes the heart structure and how it produces energy, thus increasing the risk of heart failure, according to a study.Researchers at the University of Sydney, Australia, studied donated human hearts and found that diabetes disrupts how heart cells produce energy, weakens the muscle’s structure, and triggers a buildup of stiff, fibrous tissue that makes it harder for the heart to pump.These effects were most pronounced in patients with ischemic …